Back to Markets
IFInflaRx NV

InflaRx NV

IFRXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$2.40

+0.0200 (+0.84%)

As of 05/29/26 EDT · USD

Compare
Low: $0.7400Current: $2.40High: $2.95

Key Statistics

Open

$2.40

Day High

$2.45

Day Low

$2.27

Prev. Close

$2.38

VolumeShares traded today.

667.29K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$353.50M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.34

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$2.95

52W LowLowest price over the past 52 weeks.

$0.7400

50D MAAverage closing price over the last 50 trading days.

$1.71

200D MAAverage closing price over the last 200 trading days.

$1.28

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-2.8%

1M

+21.2%

6M

+103.4%

YTD

+120.2%

1Y

+196.3%

About

Vilobelimab, sold under the brand name Gohibic, is a monoclonal antibody that is used for the treatment of COVID-19. It is a human-mouse chimeric IgG4 kappa antibody that targets human C5a in plasma.

www.inflarx.de/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade IFRX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.